We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other ...

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1. ...

The Leon’s getting on a bit now though, so does a power boost from Abt elevate the Leon back to its position near the top of the class, or would your money be better spent elsewhere? We’ve ...